- Category: Research
Research
Gout linked to worse diabetic retinopathy outcomes
Patients with T2D and gout had higher DR risk, while urate-lowering therapy was associated with lower risks of some adverse outcomes.Research
Prenatal opioid exposure tied to poorer vision, attention in kids
Evidence also points to cognitive and educational difficulties that may become more apparent with age.Research
Dexamethasone eye drops may cut invasive ROP treatment in preterm infants
A 47% relative risk reduction fell short of statistical significance, but the safety data keep topical steroids in play as a noninvasive option.Research
Simple OCT rule helps cut glaucoma false positives in myopia
Expert-derived OCT interpretation rules offer a practical way to reduce false-positive glaucoma diagnoses in myopic eyes.Research
Report: Rural residents face steep gap in retina care access
One in three rural Americans lives beyond an hour's drive of a retina specialist.Research
Industry payments tied to higher prescribing volume, costs
A Cochrane review links pharmaceutical industry payments and gifts to less appropriate prescribing, higher prescription volumes, and increased medication costs.Research
Childhood obesity linked to higher astigmatism risk
Longitudinal study found that children with a higher body mass index carried greater, dose-dependent odds of developing astigmatism years later.Research
Physical activity lowers risk for cataract development
Adults with 150 to 600 minutes of moderate-to-vigorous activity per week had a 21% lower risk of senile cataract, and genetic analysis points to a causal link.Research
I-C eye drops ease mild-to-moderate dry eye in early trial
Small open-label trial found that iota-carrageenan eye drops cut dry eye symptoms by more than half under adverse conditions, with strong tolerability and no safety flags.Research
OCT biomarkers may predict DME treatment response
Disorganization of the retinal inner layers and photoreceptor integrity biomarkers most consistently tied to visual outcomes and injection response in DME.Research
Glaukos reports positive topline phase 4 data on iDose TR in combo with cataract surgery
Latest 3-month data demonstrate clinically meaningful IOP reductions compared to cataract surgery alone.Research
Glaukos reports positive 3-year, phase 3 Epioxa clinical outcomes
Long-term extension study demonstrates clinically meaningful visual outcomes and corneal stabilization with just one treatment.Research
GLP-1 drugs increase risk for periorbital changes
GLP-1 receptor agonist use associated with higher rates of brow ptosis, dermatochalasis and corrective oculofacial procedures.Research
SpyGlass Pharma unveils positive 12-month data on BIM-IOL System
Interim findings offer a closer look at the safety and efficacy of the bimatoprost drug pad-intraocular lens system for OAG and OHT.Research
Outdoor artificial light at night tied to higher pediatric myopia risk
Study suggests living in brighter nighttime environments may increase risk for myopia development—but researchers say the findings should be interpreted with caution.Research
New data supports omega-3s for glaucoma in DED patients
Patients had roughly half the 5-year risk of developing glaucoma, though investigators stop short of claiming cause and effect.Research
Study finds routine dilation appears safe as angle-closure stays rare
Researchers caution careful assessment of patients with anatomical risk factors and awareness of medications that may increase susceptibility.Research
Antidepressant use worsens ocular surface health
Patients showed lower goblet cell density, weaker tear film stability, and more conjunctival epithelial damage—regardless of drug classResearch
Pilot study supports Rinsada for ocular surface allergen load reduction
Contralateral-eye comparison trial explores efficacy of the irrigating lid retractor for ocular lavage in symptomatic allergic conjunctivitis.Research